We are live on ! Find out more
DCM

Dupont Capital Management Portfolio holdings

AUM $2.18M
1-Year Est. Return 50.81%
This Fund
S&P 500
This Quarter Est. Return
-13.43%
1 Year Est. Return
+50.81%
3 Year Est. Return
+136.7%
5 Year Est. Return
+194.47%
10 Year Est. Return
+665.34%
AUM
$4.08B
AUM Growth
-$456M
Cap. Flow
+$224M
Cap. Flow %
5.5%
Top 10 Hldgs %
30.26%
Holding
1,293
New
325
Increased
475
Reduced
256
Closed
138

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$15.9M
2
AXP icon
American Express
AXP
+$15.6M
3
CMCSA icon
Comcast
CMCSA
+$11.3M
4
STZ icon
Constellation Brands
STZ
+$10.5M
5
MRSH
Marsh
MRSH
+$8.43M

Sector Composition

Rank Sector Weight
1 Materials 18.67%
2 Financials 12%
3 Technology 11.74%
4 Industrials 11.18%
5 Healthcare 10.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGL
701
DELISTED
Engility Holdings, Inc.
EGL
$540K 0.01%
18,960
CSL icon
702
Carlisle Companies
CSL
$14.9B
$536K 0.01%
+5,331
New +$548K
MITT
703
TPG Mortgage Investment Trust
MITT
$214M
$529K 0.01%
+11,067
New +$580K
TECD
704
DELISTED
Tech Data Corp
TECD
$526K 0.01%
6,431
+1,531
+31% +$116K
PWR icon
705
Quanta Services
PWR
$101B
$525K 0.01%
17,449
+15,406
+754% +$498K
ARRY
706
DELISTED
Array Biopharma Inc
ARRY
$524K 0.01%
36,744
-44,326
-55% -$672K
PAHC icon
707
Phibro Animal Health
PAHC
$1.38B
$520K 0.01%
16,182
WAFD icon
708
WaFd
WAFD
$2.81B
$519K 0.01%
+19,435
New +$546K
GWR
709
DELISTED
Genesee & Wyoming Inc.
GWR
$519K 0.01%
+7,011
New +$562K
MEDP icon
710
Medpace
MEDP
$16.2B
$518K 0.01%
9,781
+2,956
+43% +$162K
MNK
711
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$518K 0.01%
32,812
+21,812
+198% +$543K
ANF icon
712
Abercrombie & Fitch
ANF
$4.84B
$512K 0.01%
25,520
+9,649
+61% +$181K
SLAB icon
713
Silicon Laboratories
SLAB
$7.28B
$512K 0.01%
+6,495
New +$540K
SWN
714
DELISTED
Southwestern Energy Company
SWN
$512K 0.01%
+150,085
New +$738K
SBNY
715
DELISTED
Signature Bank
SBNY
$512K 0.01%
+4,978
New +$560K
UMPQ
716
DELISTED
Umpqua Holdings Corp
UMPQ
$509K 0.01%
+32,009
New +$602K
EW icon
717
Edwards Lifesciences
EW
$53.4B
$507K 0.01%
9,936
-57,510
-85% -$2.91M
HRC
718
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$505K 0.01%
+5,698
New +$517K
RYZ
719
Ryerson Holding Corp
RYZ
$1.5B
$504K 0.01%
79,488
RGLD icon
720
Royal Gold
RGLD
$19.1B
$503K 0.01%
+5,878
New +$453K
I
721
DELISTED
INTELSAT S. A.
I
$503K 0.01%
23,537
-7,181
-23% -$194K
AFL icon
722
Aflac
AFL
$60.7B
$502K 0.01%
11,015
-45,944
-81% -$2.04M
TECH icon
723
Bio-Techne
TECH
$11.2B
$502K 0.01%
+13,872
New +$579K
CRL icon
724
Charles River Laboratories
CRL
$13.4B
$500K 0.01%
4,414
-4,009
-48% -$502K
LFUS icon
725
Littelfuse
LFUS
$11.4B
$499K 0.01%
+2,912
New +$519K

Similar funds

Dupont Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Dupont Capital Management held 1,293 positions worth $4.08B, down 10% from $4.54B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Dupont Capital Management deployed $224M of net new capital in Q4 2018, opening 325 new positions and adding to 475 existing holdings. Its largest new stake was Equitable Holdings: 287,200 shares worth $4.78M.

By sector, the portfolio is most concentrated in Materials at 19% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $16.3M trimmed.

  • Dupont Capital Management's largest Q4 2018 buy was Equitable Holdings: 287,200 shares worth $4.78M.
  • Dupont Capital Management added most to Johnson & Johnson in Q4 2018, an estimated $15.9M increase.
  • Dupont Capital Management's biggest Q4 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $16.3M.
  • Dupont Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2018, selling an estimated $39.7M.
  • Dupont Capital Management's ten largest holdings make up 30% of its $4.08B portfolio in Q4 2018.
  • Dupont Capital Management opened 325 new positions and closed 138 in Q4 2018.
  • Dupont Capital Management's portfolio value fell 10% quarter-over-quarter to $4.08B.

Based on Dupont Capital Management's 13F filing for Q4 2018, filed 1 Feb 2019.